Disrupting the signaling pathways involved in this crosstalk, such as the chemokine ligand-receptor axis (e.g., CXCL12-CXCR4), may inhibit tumor budding and its associated invasion and metastasis. This evidence concerns the gene CXCR4 and neoplasm.